Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Lymphedema 4Neoplasm Metastasis 2Breast Neoplasms 2

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Manual Lymphatic Drainage × Clear all
NCT00852930 2017-04-11

Low Level Laser Treatment and Breast Cancer Related Lymphedema

Vanderbilt University

Phase 4 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Lymphedema

NCT00383500 2017-03-30

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

Stanford University

Phase NA Completed
75 enrolled 9 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡